Clinical trial
Study of Afimoxifene Gel to Treat Cyclic Mastalgia in Premenopausal Women
NCT00272714 · ASCEND Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00272714 |
|---|---|
| Title | Study of Afimoxifene Gel to Treat Cyclic Mastalgia in Premenopausal Women |
| Official title | A Phase II, Randomized, Double-Blind, Two-Dose, Placebo-Controlled Multicentre Study of 4-Hydroxy Tamoxifen Gel for Cyclical Mastalgia in Otherwise Healthy Pre-Menopausal Women With Regular Menstrual Cycles. |
| Lead sponsor | ASCEND Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cyclic Breast Pain, Cyclic Mastalgia |
| Intervention type | Drug |
| Interventions | Afimoxifene (0.057%) in hydroalcoholic gel |
| Enrollment | 146 |
| Start date | Mar 1, 2003 |
| Primary completion | Mar 1, 2004 |
| Completion | Apr 1, 2005 |
| First posted | Jan 9, 2006 |
| Last update posted | Aug 16, 2023 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: